10 Healthcare Focused Hedge Funds and 5 Top Stock Picks

4. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 87

Eli Lilly and Company (NYSE: LLY) discover, develop and market pharmaceutical products. Its lead product includes Basaglar, Mounjaro and Jardiance, Humalog and Humalog Mix 75/25. It is best known for selling diabetes and cancer drugs, generating billions of dollars. Its lead diabetes drug recorded a 652% jump in sales in Q3 to $1.41 billion. 

While Eli Lilly and Company (NYSE: LLY) is up by about 63% for the year, it remains one of the top stocks for healthcare-focused hedge funds due to its diversified pipeline of drugs. 

According to Insider Monkey’s Q2 2023 database, it was observed that 87 hedge funds held positions in Eli Lilly and Company (NYSE:LLY), marking an increase from 72 in the prior quarter. The combined value of these holdings exceeds $5 billion. Impax Asset Management, led by Ian Simm, stood out as the significant shareholder of the company, possessing 28,708 shares valued at $15.42 million.

Follow Eli Lilly & Co (NYSE:LLY)

[/company-follow-email]